1. Home
  2. MGF vs ELDN Comparison

MGF vs ELDN Comparison

Compare MGF & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MFS Government Markets Income Trust

MGF

MFS Government Markets Income Trust

HOLD

Current Price

$3.10

Market Cap

102.0M

Sector

Finance

ML Signal

HOLD

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

HOLD

Current Price

$1.60

Market Cap

120.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MGF
ELDN
Founded
1987
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
102.0M
120.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MGF
ELDN
Price
$3.10
$1.60
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$8.50
AVG Volume (30 Days)
104.4K
4.0M
Earning Date
01-01-0001
11-14-2025
Dividend Yield
7.64%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.91
$1.35
52 Week High
$3.46
$5.08

Technical Indicators

Market Signals
Indicator
MGF
ELDN
Relative Strength Index (RSI) 54.00 35.60
Support Level $3.09 $1.47
Resistance Level $3.13 $1.68
Average True Range (ATR) 0.02 0.17
MACD 0.00 0.02
Stochastic Oscillator 69.23 50.00

Price Performance

Historical Comparison
MGF
ELDN

About MGF MFS Government Markets Income Trust

MFS Government Markets Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to seek high current income. The fund invests a majority of the net assets, including borrowings for investment purposes, in U.S. and foreign government securities. The company invest various sectors like U.S. Treasury Securities, Mortgage-Backed Securities, Investment Grade Corporates, Municipal Bonds, Non-U.S. Government Bonds, etc, out of which maximum revenue is gained from U.S. Treasury Securities.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: